These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 28468637)

  • 1. Drug-transporter mediated interactions between anthelminthic and antiretroviral drugs across the Caco-2 cell monolayers.
    Kigen G; Edwards G
    BMC Pharmacol Toxicol; 2017 May; 18(1):20. PubMed ID: 28468637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transport characteristics of peptidomimetics. Effect of the pyrrolinone bioisostere on transport across Caco-2 cell monolayers.
    Sudoh M; Pauletti GM; Yao W; Moser W; Yokoyama A; Pasternak A; Sprengeler PA; Smith AB; Hirschmann R; Borchardt RT
    Pharm Res; 1998 May; 15(5):719-25. PubMed ID: 9619780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carrier mechanisms involved in the transepithelial transport of bis(POM)-PMEA and its metabolites across Caco-2 monolayers.
    Annaert P; Van Gelder J; Naesens L; De Clercq E; Van den Mooter G; Kinget R; Augustijns P
    Pharm Res; 1998 Aug; 15(8):1168-73. PubMed ID: 9706045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of Caco-2 subclones expressing high levels of multidrug resistance protein efflux transporter.
    Horie K; Tang F; Borchardt RT
    Pharm Res; 2003 Feb; 20(2):161-8. PubMed ID: 12636153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Absorption and transport of isoflavonoid compounds from Tongmai formula across human intestinal epithelial (Caco-2) cells in vitro].
    Wang FR; Yang XW
    Zhongguo Zhong Yao Za Zhi; 2017 Aug; 42(16):3206-3212. PubMed ID: 29171242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of the coumarinic acid-based cyclic prodrug of the opioid peptide DADLE.
    Tang F; Borchardt RT
    Pharm Res; 2002 Jun; 19(6):787-93. PubMed ID: 12134948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells.
    Makhey VD; Guo A; Norris DA; Hu P; Yan J; Sinko PJ
    Pharm Res; 1998 Aug; 15(8):1160-7. PubMed ID: 9706044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.
    Profit L; Eagling VA; Back DJ
    AIDS; 1999 Sep; 13(13):1623-7. PubMed ID: 10509562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of an acyloxyalkoxy-based cyclic prodrug of the opioid peptide DADLE.
    Tang F; Borchardt RT
    Pharm Res; 2002 Jun; 19(6):780-6. PubMed ID: 12134947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective transport and uptake of propranolol across human intestinal Caco-2 cell monolayers.
    Wang Y; Cao J; Wang X; Zeng S
    Chirality; 2010 Mar; 22(3):361-8. PubMed ID: 19575464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transepithelial transport of artepillin C in intestinal Caco-2 cell monolayers.
    Konishi Y
    Biochim Biophys Acta; 2005 Jul; 1713(2):138-44. PubMed ID: 16004960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic roles of neutral surfactants on concurrent polarized and passive membrane transport of a model peptide in Caco-2 cells.
    Nerurkar MM; Ho NF; Burton PS; Vidmar TJ; Borchardt RT
    J Pharm Sci; 1997 Jul; 86(7):813-21. PubMed ID: 9232522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transport characteristics of tryptanthrin and its inhibitory effect on P-gp and MRP2 in Caco-2 cells.
    Zhu X; Zhang X; Ma G; Yan J; Wang H; Yang Q
    J Pharm Pharm Sci; 2011; 14(3):325-35. PubMed ID: 21824448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The H2 receptor antagonist nizatidine is a P-glycoprotein substrate: characterization of its intestinal epithelial cell efflux transport.
    Dahan A; Sabit H; Amidon GL
    AAPS J; 2009 Jun; 11(2):205-13. PubMed ID: 19319690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretory transport of ranitidine and famotidine across Caco-2 cell monolayers.
    Lee K; Ng C; Brouwer KL; Thakker DR
    J Pharmacol Exp Ther; 2002 Nov; 303(2):574-80. PubMed ID: 12388638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcellular and lipophilic complex-enhanced intestinal absorption of human growth hormone.
    Wu SJ; Robinson JR
    Pharm Res; 1999 Aug; 16(8):1266-72. PubMed ID: 10468030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular Uptake and Transport Characteristics of FL118 Derivatives in Caco-2 Cell Monolayers.
    Zhou Y; Hu W; Zhang X; Wang Y; Zhuang W; Li F; Li Q
    Chem Pharm Bull (Tokyo); 2021; 69(11):1054-1060. PubMed ID: 34719586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transport of thalidomide by the human intestinal caco-2 monolayers.
    Zhou S; Li Y; Kestell P; Schafer P; Chan E; Paxton JW
    Eur J Drug Metab Pharmacokinet; 2005; 30(1-2):49-61. PubMed ID: 16010862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRP2 mediated drug-drug interaction: indomethacin increases sulfasalazine absorption in the small intestine, potentially decreasing its colonic targeting.
    Dahan A; Amidon GL
    Int J Pharm; 2010 Feb; 386(1-2):216-20. PubMed ID: 19944137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleobase- and p-glycoprotein-mediated transport of AG337 in a Caco-2 cell culture model.
    Hu M; Chen J
    Mol Pharm; 2004; 1(3):194-200. PubMed ID: 15981922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.